Multiples in Dermatology: Markers for Special Considerations in Diagnosis, Therapy, and Prognosis

被引:0
|
作者
Trevino, Julian [1 ]
Grosshandler, Josh [1 ]
Chen, Amy Y-Y [1 ]
Chiang, Charles [1 ]
Serrao, Rocco [1 ]
Dohil, Magdalene [2 ]
机构
[1] Wright State Univ, Boonshoft Sch Med, Dept Dermatol, Dayton, OH 45435 USA
[2] Rady Childrens Hosp San Diego, San Diego, CA USA
关键词
DIFFUSE NEONATAL HEMANGIOMATOSIS; PEUTZ-JEGHERS-SYNDROME; HEREDITARY HEMORRHAGIC TELANGIECTASIA; CARNEY-COMPLEX; DIFFERENTIAL-DIAGNOSIS; INFANTILE HEMANGIOMAS; ATAXIA-TELANGIECTASIA; CAUSE NOONAN; LENTIGINOSIS; DISEASE;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Multiples of certain cutaneous lesions should alert the clinician to a wider differential diagnosis and possible systemic associations although the individual skin lesion is often benign in nature and banal in appearance. This article focuses on such findings in selected multiple cutaneous lesions that may be classified according to the primary cutaneous feature as vascular, pigmentary, nevoid hamartomas, and tumors/neoplastic conditions. The clinical presentation of each entity and its significance, appropriate diagnostic evaluation, therapeutic and prognostic considerations and pertinent differential diagnoses will be reviewed.
引用
收藏
页码:812 / 817
页数:6
相关论文
共 50 条
  • [21] Diagnosis, prognosis, and therapy selection
    Lipp, Elizabeth
    GENETIC ENGINEERING NEWS, 2007, 27 (03): : 1 - +
  • [22] Anticoagulant therapy in the elderly: special considerations
    Siguret, Virginie
    Gouin, Isabelle
    Pautas, Eric
    HEMATOLOGIE, 2009, 15 (03): : 223 - 234
  • [23] Special considerations in the therapy of diabetic hypertension
    Guzmán, CB
    Sowers, JR
    PROGRESS IN CARDIOVASCULAR DISEASES, 1999, 41 (06) : 461 - 470
  • [24] Prostate tumor markers: diagnosis, prognosis and management
    Lawisch, Gabriela Kniphoff da Silva
    Dexheimer, Georgia Muccillo
    Biolchi, Vanderlei
    Seewald, Rafael Armando
    Chies, Jose Artur Bogo
    GENETICS AND MOLECULAR BIOLOGY, 2023, 46 (03)
  • [25] Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis
    Rahnemai-Azar, Amir A.
    Weisbrod, Allison
    Dillhoff, Mary
    Schmidt, Carl
    Pawlik, Timothy M.
    SURGICAL ONCOLOGY-OXFORD, 2017, 26 (02): : 125 - 137
  • [26] LYMPHOCYTE MARKERS IN THE DIAGNOSIS AND PROGNOSIS OF PRIMARY HEMATURIA
    ESQUENAZI, V
    PARDO, T
    STRAUSS, J
    PARDO, V
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 830 - 830
  • [27] LYMPHOCYTE MARKERS IN THE DIAGNOSIS AND PROGNOSIS OF PRIMARY HEMATURIA
    ESQUENAZI, V
    PARDO, T
    STRAUSS, J
    PARDO, V
    HUMAN IMMUNOLOGY, 1981, 3 (04) : 361 - 361
  • [28] Molecular Markers: From Diagnosis to Prognosis in 2013
    Teixeira G.V.
    Cernea C.R.
    Current Otorhinolaryngology Reports, 2014, 2 (1) : 35 - 43
  • [29] TUMOR MARKERS IN DIAGNOSIS AND PROGNOSIS OF THYROID NEOPLASMS
    Ludvikova, Marie
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3553 - 3553
  • [30] Novel markers for heart failure diagnosis and prognosis
    Lee, DS
    Vasan, RS
    CURRENT OPINION IN CARDIOLOGY, 2005, 20 (03) : 201 - 210